Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Feb 06, 2020

SELL
$69.39 - $97.59 $1.24 Million - $1.75 Million
-17,923 Closed
0 $0
Q3 2019

Nov 12, 2019

SELL
$64.17 - $84.08 $92,533 - $121,243
-1,442 Reduced 7.45%
17,923 $1.27 Million
Q2 2019

Aug 01, 2019

BUY
$70.1 - $85.17 $80,334 - $97,604
1,146 Added 6.29%
19,365 $0
Q4 2018

Jan 30, 2019

SELL
$83.85 - $110.34 $7,714 - $10,151
-92 Reduced 0.5%
18,219 $1.57 Million
Q3 2018

Nov 05, 2018

BUY
$97.14 - $113.31 $5,439 - $6,345
56 Added 0.31%
18,311 $0
Q2 2018

Jul 18, 2018

BUY
$74.5 - $108.91 $166,507 - $243,413
2,235 Added 13.95%
18,255 $0
Q1 2018

May 08, 2018

BUY
$58.36 - $83.18 $167,551 - $238,809
2,871 Added 21.83%
16,020 $0
Q4 2017

Feb 06, 2018

BUY
$77.49 - $98.41 $1.02 Million - $1.29 Million
13,149
13,149 $0

Others Institutions Holding HSKA

About HESKA CORP


  • Ticker HSKA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 10,818,900
  • Description
  • Heska Corporation sells veterinary and animal health diagnostic and specialty products for canine and feline healthcare markets in the United States, Canada, Mexico, Australia, France, Germany, Italy, Malaysia, Spain, and Switzerland. The company offers Element DC, Element DCX, Element DC5x veterinary chemistry analyzers for blood chemistry and ...
More about HSKA
Track This Portfolio

Track Pendal Group LTD Portfolio

Follow Pendal Group LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pendal Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Pendal Group LTD with notifications on news.